+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow



The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow



Fertility and Sterility 90(5): 1574-1578



To evaluate the effect of the levonorgestrel intrauterine system (LNG-IUS) and TCU 380A on the subendometrial vascularization and the uterine artery blood flow during the midluteal phase. Prospective clinical trial. Teaching hospital. The trial included 27 patients who received the LNG-IUS compared with 25 patients who received the TCU 380A. The subendometrial blood flow was evaluated using power Doppler analysis, uterine artery pulsatility index (PI), and resistance index (RI) just before inserting the intrauterine device in the midluteal phase and 3 months after. Power Doppler analysis, PI, RI, and endometrial thickness. There were no significant differences in subendometrial vascularization between the groups. Pulsatility index and RI variability (before and after) increased and endometrial thickness reduced in LNG-IUS users. We used the multiple logistic regression model to examine the potential confounding bias (age and parity). The LNG-IUS was independently associated with increased PI. No subendometrial microvascularization difference was found between the groups. It is the first direct evidence that LNG-IUS reduced uterine artery blood flow, even after controlling for age and parity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056312952

Download citation: RISBibTeXText

PMID: 18191844

DOI: 10.1016/j.fertnstert.2007.10.004


Related references

Subendometrial microvascularization and uterine artery blood flow in IUD-induced side effects (levonorgestrel intrauterine system and copper intrauterine device). Contraception 78(4): 324-327, 2008

Effect of the copper-intrauterine device (TCu 380A) on subendometrial microvascularization and uterine artery blood flow. Fertility and Sterility 86(6): 1780-1782, 2006

Comparison of uterine artery blood flow with levonorgestrel intrauterine system and copper intrauterine device. Contraception 83(6): 578-581, 2011

Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow. European Journal of Contraception and Reproductive Health Care 14(3): 240-244, 2009

The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years). Minerva Ginecologica 54(3): 271-278, 2002

Effects of a levonorgestrel intrauterine system versus a copper intrauterine device on menstrual changes and uterine artery Doppler. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 145(1): 18-22, 2019

The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women. Human Reproduction 13(12): 3379-3383, 1998

The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women. Human Reproduction 13(12): 3379-3383, 1998

Effects of a copper-medicated intrauterine device on ovarian artery, uterine artery, and intrauterine blood flow. Gynecologic and Obstetric Investigation 66(4): 253-256, 2008

Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system. Journal of Obstetrics and Gynaecology Research 42(5): 554-559, 2016

Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Contraception 86(5): 458-463, 2012

Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use. European Journal of Contraception & Reproductive Health Care 20(1): 57-63, 2015

The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion. Ultrasound in Obstetrics and Gynecology 27(3): 316-319, 2006

Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study. Contraception 79(1): 24-28, 2009

Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertility and Sterility 39(2): 187-192, 1983